Mark Cuban jumps out of the Shark Tank and into generic pharma with a plan to offer dirt-cheap drugs

In an effort to offer low-cost alternatives to pricey generic medicines, billionaire investor Mark Cuban has put his name to a new company dubbed Mark Cuban Cost Plus Drugs — an on-the-nose moniker for sure, but one with the serious ambition of undercutting the market on targeted meds.